tiprankstipranks
Eledon Pharmaceuticals, Inc. (DE:2TK)
NASDAQ:2TK
Germany Market

Eledon Pharmaceuticals (2TK) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Buy
12Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Eledon Pharmaceuticals, Inc.’s (2TK) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Eledon Pharmaceuticals, Inc. is a Buy.
Eledon Pharmaceuticals, Inc.’s (2TK) 20-Day exponential moving average is 3.11, while Eledon Pharmaceuticals, Inc.’s (2TK) share price is €3.36, making it a Sell.
Eledon Pharmaceuticals, Inc.’s (2TK) 50-Day exponential moving average is 2.93, while Eledon Pharmaceuticals, Inc.’s (2TK) share price is €3.36, making it a Buy.

Eledon Pharmaceuticals (2TK) Pivot Points

Jun 08, 2026, 09:52 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.92
2.92
2.92
2.92
2.92
2.92
2.92
Fibonacci
2.92
2.92
2.92
2.92
2.92
2.92
2.92
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Eledon Pharmaceuticals (2TK) Moving Averages

Jun 08, 2026, 09:52 PM
Period
Simple
Exponential
MA5
3.04Sell
3.03Sell
MA10
3.15Sell
3.09Sell
MA20
3.16Sell
3.11Sell
MA50
2.96Buy
2.93Buy
MA100
2.48Buy
2.65Buy
MA200
2.24Buy
2.49Buy
Eledon Pharmaceuticals, Inc.’s (2TK) 10-Day exponential moving average is 3.09, while Eledon Pharmaceuticals, Inc.’s (2TK) share price is €3.36, making it a Sell.
Eledon Pharmaceuticals, Inc.’s (2TK) 100-Day exponential moving average is 2.65, while Eledon Pharmaceuticals, Inc.’s (2TK) share price is €3.36, making it a Buy.
Eledon Pharmaceuticals, Inc.’s (2TK) stock price is €3.36 and Eledon Pharmaceuticals, Inc.’s (2TK) 50-day simple moving average is 2.96, creating a Buy signal.
Eledon Pharmaceuticals, Inc.’s (2TK) stock price is €3.36 and Eledon Pharmaceuticals, Inc.’s (2TK) 100-day simple moving average is 2.48, creating a Buy signal.
Eledon Pharmaceuticals, Inc.’s (2TK) stock price is €3.36 and Eledon Pharmaceuticals, Inc.’s (2TK) 200-day simple moving average is 2.24, creating a Buy signal.

Eledon Pharmaceuticals (2TK) Technical Indicators

Jun 08, 2026, 09:52 PM
Name
Value
Implied Action
RSI (14)
45.51
Neutral
STOCH (9,6)
7.41
Buy
STOCHRSI (14)
7.41
Buy
MACD (12,26)
0.02
Buy
ADX (14)
17.16
Buy
Williams %R
-77.78
Buy
CCI (14)
-110.66
Buy
ATR (14)
0.07
-
Ultimate Oscillator
30.29
Neutral
ROC
-5.06
Sell
Eledon Pharmaceuticals, Inc.’s (2TK) Relative Strength Index (RSI) is 45.51, creating a Neutral signal.
Eledon Pharmaceuticals, Inc.’s (2TK) Trend Strength Indicator (ADX) is 17.16, creating a Buy signal.
Eledon Pharmaceuticals, Inc.’s (2TK) Commodity Channel Index (CCI) is -110.66, creating a Buy signal.
Eledon Pharmaceuticals, Inc.’s (2TK) Price Rate of Change (ROC) is -5.06, creating a Sell signal.

FAQ

Is 2TK a Buy, Hold, or Sell?
Based on 2TK’s technical indicators, 2TK is a Buy.
    What is 2TK’s RSI (14)?
    2TK’s RSI (14) is 45.51, which suggests 2TK is a Neutral.
      What is 2TK’s MACD?
      2TK’s MACD is 0.02, which suggests 2TK is a Buy.
        What is 2TK’s 5-day moving average?
        2TK’s 5-day moving average is 3.04, which suggests 2TK is a Sell.
          What is 2TK’s 20-day moving average?
          2TK 20-day moving average is 3.16, which suggests 2TK is a Sell.
            What is 2TK’s 50-day moving average?
            2TK’s 50-day moving average is 2.96, which suggests 2TK is a Buy.
              What is 2TK’s 200-day moving average?
              2TK’s 200-day moving average is 2.24, which suggests 2TK is a Buy.
                What is 2TK’s Williams % R (14)?
                2TK’s Williams % R (14) is -77.78, which suggests 2TK is a Buy.
                  What is 2TK’s CCI (14)?
                  2TK’s CCI (14) is -110.66, which suggests 2TK is a Buy.
                    What is the share price of Eledon Pharmaceuticals, Inc.?